FDA Inspection 986276 — Abbott Laboratories

Abbott Laboratories — FEI 2919069

The FDA completed an inspection of Abbott Laboratories on August 10, 2016 in Santa Clara, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 10, 2016
Fiscal Year
2016
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Santa Clara, CA (United States)

Citations

IDCFRDescription
319221 CFR 820.30(g)Design validation - user needs and intended uses
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
73221 CFR 803.50(a)(2)Individual Report of Malfunction